Search Results - "Agostoni, Valentina"

Refine Results
  1. 1
  2. 2

    Positively charged cyclodextrins as effective molecular transporters of active phosphorylated forms of gemcitabine into cancer cells by Rodriguez-Ruiz, Violeta, Maksimenko, Andrey, Salzano, Giuseppina, Lampropoulou, Maria, Lazarou, Yannis G., Agostoni, Valentina, Couvreur, Patrick, Gref, Ruxandra, Yannakopoulou, Konstantina

    Published in Scientific reports (21-08-2017)
    “…Positively charged cyclodextrins (PCCDs) are molecular carriers of particular interest for their ability to readily enter into cancer cells. Of main interest,…”
    Get full text
    Journal Article
  3. 3

    Host–Guest Interactions in Fe(III)-Trimesate MOF Nanoparticles Loaded with Doxorubicin by Anand, Resmi, Borghi, Francesco, Manoli, Francesco, Manet, Ilse, Agostoni, Valentina, Reschiglian, Pierluigi, Gref, Ruxandra, Monti, Sandra

    Published in The journal of physical chemistry. B (24-07-2014)
    “…Doxorubicin (DOX) entrapment in porous Fe(III)–trimesate metal organic frameworks (MIL-100(Fe)) nanoparticles was investigated in neutral Tris buffer via…”
    Get full text
    Journal Article
  4. 4

    A “Ship in a Bottle” Strategy To Load a Hydrophilic Anticancer Drug in Porous Metal Organic Framework Nanoparticles: Efficient Encapsulation, Matrix Stabilization, and Photodelivery by di Nunzio, Maria Rosaria, Agostoni, Valentina, Cohen, Boiko, Gref, Ruxandra, Douhal, Abderrazzak

    Published in Journal of medicinal chemistry (23-01-2014)
    “…An essential challenge in the development of nanosized metal organic framework (nanoMOF) materials in biomedicine is to develop a strategy to stabilize their…”
    Get full text
    Journal Article
  5. 5
  6. 6

    A non-covalent “click chemistry” strategy to efficiently coat highly porous MOF nanoparticles with a stable polymeric shell by Aykaç, Ahmet, Noiray, Magali, Malanga, Milo, Agostoni, Valentina, Casas-Solvas, Juan Manuel, Fenyvesi, Éva, Gref, Ruxandra, Vargas-Berenguel, Antonio

    “…Metal-organic framework nanoparticles (nanoMOFs) are biodegradable highly porous materials with a remarkable ability to load therapeutic agents with a wide…”
    Get full text
    Journal Article
  7. 7

    Preclinical evaluation of liposome-supported peritoneal dialysis for the treatment of hyperammonemic crises by Matoori, Simon, Forster, Vincent, Agostoni, Valentina, Bettschart-Wolfensberger, Regula, Bektas, Rima Nadine, Thöny, Beat, Häberle, Johannes, Leroux, Jean-Christophe, Kabbaj, Meriam

    Published in Journal of controlled release (10-12-2020)
    “…Liposome-supported peritoneal dialysis (LSPD) with transmembrane pH-gradient liposomes was previously shown to enhance ammonia removal in cirrhotic rats and…”
    Get full text
    Journal Article
  8. 8

    Efficient "green" encapsulation of a highly hydrophilic anticancer drug in metal-organic framework nanoparticles by Rodriguez-Ruiz, Violeta, Maksimenko, Andrei, Anand, Resmi, Monti, Sandra, Agostoni, Valentina, Couvreur, Patrick, Lampropoulou, Maria, Yannakopoulou, Konstantina, Gref, Ruxandra

    Published in Journal of drug targeting (14-09-2015)
    “…Metal-organic frameworks (MOFs) are coordination polymers of interest for biomedical applications. Of particular importance, nanoparticles made of iron(III)…”
    Get full text
    Journal Article
  9. 9

    Liposome-supported peritoneal dialysis in the treatment of severe hyperammonemia: An investigation on potential interactions by Giacalone, Giovanna, Matoori, Simon, Agostoni, Valentina, Forster, Vincent, Kabbaj, Meriam, Eggenschwiler, Sarah, Lussi, Martin, De Gottardi, Andrea, Zamboni, Nicola, Leroux, Jean-Christophe

    Published in Journal of controlled release (28-05-2018)
    “…Peritoneal dialysis (PD) performed with transmembrane pH-gradient liposomes was reported to efficiently remove ammonia from the body, representing a promising…”
    Get full text
    Journal Article
  10. 10

    A “green” strategy to construct non-covalent, stable and bioactive coatings on porous MOF nanoparticles by Agostoni, V., Horcajada, P., Noiray, M., Malanga, M., Aykaç, A., Jicsinszky, L., Vargas-Berenguel, A., Semiramoth, N., Daoud-Mahammed, S., Nicolas, V., Martineau, C., Taulelle, F., Vigneron, J., Etcheberry, A., Serre, C., Gref, R.

    Published in Scientific reports (21-01-2015)
    “…Nanoparticles made of metal-organic frameworks (nanoMOFs) attract a growing interest in gas storage, separation, catalysis, sensing and more recently,…”
    Get full text
    Journal Article
  11. 11

    β-Cyclodextrin polymer nanoparticles as carriers for doxorubicin and artemisinin: a spectroscopic and photophysical study by Anand, Resmi, Manoli, Francesco, Manet, Ilse, Daoud-Mahammed, Samia, Agostoni, Valentina, Gref, Ruxandra, Monti, Sandra

    Published in Photochemical & photobiological sciences (01-08-2012)
    “…The association of doxorubicin (DOX) and artemisinin (ART) to a β-CyD-epichlorohydrin crosslinked polymer (pβ-CyD), organized in nanoparticles of ca. 15 nm…”
    Get more information
    Journal Article
  12. 12

    Liposome-Supported Peritoneal Dialysis for the Treatment of Hyperammonemia-Associated Encephalopathy by Agostoni, Valentina, Lee, Soo Hyeon, Forster, Vincent, Kabbaj, Meriam, Bosoi, Cristina R., Tremblay, Mélanie, Zadory, Matthias, Rose, Christopher F., Leroux, Jean-Christophe

    Published in Advanced functional materials (13-12-2016)
    “…Hyperammonemia can lead to cerebral dysfunction, encephalopathy, coma, and death if not treated adequately. The poor prognosis associated with this condition…”
    Get full text
    Journal Article
  13. 13
  14. 14
  15. 15
  16. 16

    Hyperammonemia: Liposome-Supported Peritoneal Dialysis for the Treatment of Hyperammonemia-Associated Encephalopathy (Adv. Funct. Mater. 46/2016) by Agostoni, Valentina, Lee, Soo Hyeon, Forster, Vincent, Kabbaj, Meriam, Bosoi, Cristina R., Tremblay, Mélanie, Zadory, Matthias, Rose, Christopher F., Leroux, Jean-Christophe

    Published in Advanced functional materials (01-12-2016)
    “…On page 8382, J.‐C. Leroux and co‐workers describe a novel approach for treating hyperammonemia induced encephalopathy, based on the peritoneal infusion of…”
    Get full text
    Journal Article
  17. 17
  18. 18
  19. 19

    In Vitro Comparison of Three Different Chimeric Receptor-modified Effector T-cell Populations for Leukemia Cell Therapy by PIZZITOLA, Irene, AGOSTONI, Valentina, CRIBIOLI, Elisabetta, PULE, Martin, ROUSSEAU, Raphael, FINNEY, Helene, LAWSON, Alastair, BIONDI, Andrea, BIAGI, Ettore, MARIN, Virna

    Published in Journal of immunotherapy (1997) (01-07-2011)
    “…The identification of the optimal T-cell effector subtype is a crucial issue for adoptive cell therapy with chimeric receptor-modified T cells. The ideal T…”
    Get full text
    Journal Article
  20. 20